I-MAB(IMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IMAB I-MAB

交易中 02-25 10:55:44 EST

4.63

+0.00

0.00%

最高4.63	最低4.63	成交量0.00
今开4.63	昨收4.63	日振幅0.00%
总市值5.34亿	流通市值2.23亿	总股本1.15亿
成交额702.95万	换手率0.00%	流通股本4,823万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IMAB","market":"US","secType":"STK","nameCN":"I-MAB","latestPrice":4.63,"timestamp":1761768000000,"preClose":4.63,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":48234000,"shares":115266053,"eps":-0.490217,"marketStatus":"交易中","change":0,"latestTime":"02-25 10:55:44 EST","open":4.63,"high":4.63,"low":4.63,"amount":7029525.77397,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.490217,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772053200000},"marketStatusCode":2,"symbolChange":{"newSymbol":"NBP","executeDate":"2025-10-30"},"adr":0,"adrRate":2.3,"listingDate":1579237200000,"exchange":"NASDAQ","adjPreClose":4.63,"volumeRatio":0},"requestUrl":"/m/hq/s/IMAB","defaultTab":"news","newsList":[{"id":"1176185820","title":"I-Mab （纳斯达克：IMAB）将于2025年10月30日转型为Novabridge Biosciences （纳斯达克：NBP），全新品牌和标志将体现向全球生物科技平台的战略转型","url":"https://stock-news.laohu8.com/highlight/detail?id=1176185820","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176185820?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:03","pubTimestamp":1761742984,"startTime":"0","endTime":"0","summary":"I-Mab（纳斯达克：IMAB）将于2025年10月30日转型为Novabridge Biosciences（纳斯达克：NBP），全新品牌和标志将体现向全球生物科技平台的战略转型。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMAB","BK4505","BK4139","BK4535","BK4526","NBP"],"gpt_icon":0},{"id":"2576142540","title":"I-Mab“再次转身”：香港IPO双上市+改名NovaBridge，重返亚太市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2576142540","media":"Minhua笔记","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576142540?lang=zh_cn&edition=full","pubTime":"2025-10-18 18:22","pubTimestamp":1760782971,"startTime":"0","endTime":"0","summary":"更名NovaBridge Biosciences，从“专注美国”转向亚太地区注资3700万美元成立眼科NewCo Visara计划收购VEGF-A/ANG2双特异融合蛋白VIS-101继续开发CLDN18.2x4-1BB双抗givastomig公司股价周五下跌20%，反映市场对战略不确定性的担忧在剥离中国业务成为专注美国市场的生物技术公司后不到两年后，I-Mab Biopharma再次公布新战略，包括寻求香港IPO、维持纳斯达克上市，并改名NovaBridge Biosciences，此举旨在重新确立其在亚太地区的地位。伴随商业模式的改变，天境生物还计划更名为 NovaBridge Biosciences，但需经下周股东大会批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251018183256a46678bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251018183256a46678bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4526","BK4505","IMAB","BK4535","BK4139"],"gpt_icon":0},{"id":"1178634427","title":"I-Mab公布战略转型计划，拟打造全球生物科技平台，寻求在香港上市，并更名为Novabridge Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=1178634427","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1178634427?lang=zh_cn&edition=full","pubTime":"2025-10-17 04:06","pubTimestamp":1760645171,"startTime":"0","endTime":"0","summary":"I-Mab公布战略转型计划，拟打造全球生物科技平台，寻求在香港上市，并更名为Novabridge Biosciences","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ08YR35.GBP","IMAB","BK4139","BK1191","01177","BK1574","BK4526","BK1521","BK1583","01952","BK4535","IE00BZ08YS42.EUR","BK4505","IE00BZ08YT58.USD","BK1589","BK1161"],"gpt_icon":0},{"id":"2517451644","title":"天境生物下跌2.97%，报0.841美元/股，总市值6852.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517451644","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517451644?lang=zh_cn&edition=full","pubTime":"2025-03-08 02:20","pubTimestamp":1741371601,"startTime":"0","endTime":"0","summary":"3月8日，天境生物盘中下跌2.97%，截至02:20，报0.841美元/股，成交8.01万美元，总市值6852.61万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报。资料显示，天境公司是一家境外注册成立的离岸控股母公司,通过境内子公司天境生物开展业务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/08022048605076.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4526","BK4505","IMAB","BK4139","BK4535"],"gpt_icon":0},{"id":"2517112164","title":"天境生物上涨2.05%，报0.919美元/股，总市值7493.21万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517112164","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517112164?lang=zh_cn&edition=full","pubTime":"2025-03-06 23:37","pubTimestamp":1741275446,"startTime":"0","endTime":"0","summary":"3月6日，天境生物盘中上涨2.05%，截至23:37，报0.919美元/股，成交6.75万美元，总市值7493.21万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报。资料显示，天境公司是一家境外注册成立的离岸控股母公司,通过境内子公司天境生物开展业务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/06233748576712.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4505","BK4535","BK4526","BK4139","IMAB"],"gpt_icon":0},{"id":"2514331741","title":"济川药业：公司与天境生物合作的伊坦生长激素上市申请已于2024年12月获药品评价中心受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2514331741","media":"互动易","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514331741?lang=zh_cn&edition=full","pubTime":"2025-02-28 16:30","pubTimestamp":1740731402,"startTime":"0","endTime":"0","summary":"有投资者向济川药业提问， 咱们那个儿童增长药，大概什么时候能够上市？或者估计什么时候能够上市？公司回答表示，尊敬的投资者，您好。公司与天境生物合作的伊坦生长激素上市申请已于2024年12月获药品评价中心受理。如有重大进展或变化，公司也将严格按照相关法律法规要求，及时履行信息披露义务。感谢您的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228163752a25795cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228163752a25795cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0188","BK0077","BK0187","BK0012","BK0028","600566","BK0201","BK0239","IMAB"],"gpt_icon":0},{"id":"2514018899","title":"天境生物上涨3.09%，报0.97美元/股，总市值7905.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514018899","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514018899?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:41","pubTimestamp":1740494511,"startTime":"0","endTime":"0","summary":"2月25日，天境生物盘中上涨3.09%，截至22:41，报0.97美元/股，成交2050.0美元，总市值7905.61万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报。资料显示，天境公司是一家境外注册成立的离岸控股母公司,通过境内子公司天境生物开展业务。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/25224148383755.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4526","BK4535","BK4139","IMAB","BK4505"],"gpt_icon":0},{"id":"2513296253","title":"天境生物上涨2.4%，报0.99美元/股，总市值8067.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296253","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296253?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:40","pubTimestamp":1740148856,"startTime":"0","endTime":"0","summary":"2月21日，天境生物盘中上涨2.4%，截至22:40，报0.99美元/股，成交2.77万美元，总市值8067.79万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报。资料显示，天境公司是一家境外注册成立的离岸控股母公司,通过境内子公司天境生物开展业务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/21224048320232.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4526","BK4505","BK4139","BK4535","IMAB"],"gpt_icon":0},{"id":"2510403387","title":"天境生物盘中异动 大幅拉升6.30%报0.994美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510403387","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510403387?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:35","pubTimestamp":1739284544,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时35分，天境生物股票出现波动，股价急速上涨6.30%。截至发稿，该股报0.994美元/股，成交量1.8758万股，换手率0.02%，振幅9.53%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。天境生物股票所在的生物技术行业中，整体跌幅为0.83%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235449881bdc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502112235449881bdc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4535","BK4139","IMAB","BK4526"],"gpt_icon":0},{"id":"2510931908","title":"天境生物下跌2.8%，报0.953美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2510931908","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510931908?lang=zh_cn&edition=full","pubTime":"2025-02-11 01:43","pubTimestamp":1739209400,"startTime":"0","endTime":"0","summary":"2月11日，天境生物(IMAB)盘中下跌2.8%，截至01:43，报0.953美元/股，成交60.36万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/11014348064599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IMAB","BK4139","BK4526","BK4535","BK4505"],"gpt_icon":0},{"id":"2510186985","title":"天境生物盘中异动 股价大涨5.08%报1.030美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510186985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510186985?lang=zh_cn&edition=full","pubTime":"2025-02-10 23:16","pubTimestamp":1739200596,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日23时16分，天境生物股票出现波动，股价大幅拉升5.08%。截至发稿，该股报1.030美元/股，成交量14.6091万股，换手率0.18%，振幅4.67%。天境生物股票所在的生物技术行业中，整体跌幅为0.05%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2436.25%、1477.68%、932.99%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 ，振幅分别为69.83%、66.09%、50.50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210231636961e09ac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210231636961e09ac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4526","IMAB","BK4139","BK4505"],"gpt_icon":0},{"id":"2509523325","title":"天境生物上涨2.03%，报0.98美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2509523325","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509523325?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:55","pubTimestamp":1738770948,"startTime":"0","endTime":"0","summary":"2月5日，天境生物(IMAB)盘中上涨2.03%，截至23:55，报0.98美元/股，成交7214.0美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/05235547974963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4505","BK4535","BK4526","IMAB","BK4139"],"gpt_icon":0},{"id":"2508457797","title":"天境生物盘中异动 大幅上涨6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508457797","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508457797?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:31","pubTimestamp":1738679493,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时31分，天境生物股票出现异动，股价大幅上涨6.18%。截至发稿，该股报1.010美元/股，成交量1.1086万股，换手率0.01%，振幅6.30%。天境生物股票所在的生物技术行业中，整体跌幅为0.58%。其相关个股中，Azitra Inc、Evaxion Biotech As、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为834.81%、673.74%、185.13%，振幅较大的相关个股有Omega Therapeutics, Inc.、Azitra Inc、Evaxion Biotech As，振幅分别为17.57%、13.82%、8.75%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223133987a4a62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204223133987a4a62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4526","BK4139","BK4505","IMAB","BK4535"],"gpt_icon":0},{"id":"2508129338","title":"天境生物盘中异动 大幅跳水6.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508129338","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508129338?lang=zh_cn&edition=full","pubTime":"2025-02-04 01:50","pubTimestamp":1738605006,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日01时50分，天境生物股票出现异动，股价快速跳水6.56%。截至发稿，该股报0.953美元/股，成交量10.0152万股，换手率0.12%，振幅4.90%。天境生物股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Hcw Biologics Inc.、Invivyd, Inc.、Gh Research Plc涨幅较大，Hcw Biologics Inc.、Cyclerion Therapeutics, Inc.、Briacell Therapeutics Corp.较为活跃，换手率分别为688.32%、570.43%、460.64%，振幅较大的相关个股有Hcw Biologics Inc.、Invivyd, Inc.、Briacell Therapeutics Corp.，振幅分别为170.13%、126.64%、63.94%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502040150069617184e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502040150069617184e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4526","IMAB","BK4505","BK4535"],"gpt_icon":0},{"id":"2508993666","title":"天境生物下跌2.83%，报1.03美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2508993666","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508993666?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:30","pubTimestamp":1738344611,"startTime":"0","endTime":"0","summary":"2月1日，天境生物(IMAB)盘中下跌2.83%，截至01:30，报1.03美元/股，成交7.65万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/02/01013047922576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IMAB","BK4505","BK4526","BK4139","BK4535"],"gpt_icon":0},{"id":"2507954416","title":"天境生物下跌2.78%，报1.05美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2507954416","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507954416?lang=zh_cn&edition=full","pubTime":"2025-01-29 02:23","pubTimestamp":1738088585,"startTime":"0","endTime":"0","summary":"1月29日，天境生物(IMAB)盘中下跌2.78%，截至02:23，报1.05美元/股，成交29.3万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/29022347883576.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4505","BK4526","BK4139","BK4535","IMAB"],"gpt_icon":0},{"id":"2505665408","title":"天境生物盘中异动 早盘股价大涨6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505665408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505665408?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:36","pubTimestamp":1737729360,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时36分，天境生物股票出现波动，股价大幅拉升6.13%。截至发稿，该股报1.13美元/股，成交量6.6195万股，换手率0.08%，振幅1.89%。天境生物股票所在的生物技术行业中，整体涨幅为0.03%。其相关个股中，Pmgc Holdings Inc.、Evaxion Biotech As、Transcode Therapeutics, Inc.涨幅较大，Evaxion Biotech As、Pmgc Holdings Inc.、Avenue Therapeutics, Inc.较为活跃，换手率分别为2088.36%、1271.50%、847.30%，振幅较大的相关个股有Pmgc Holdings Inc.、Evaxion Biotech As、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为40.91%、34.10%、24.58%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223600abb74f91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223600abb74f91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IMAB","BK4535","BK4526","BK4505","BK4139"],"gpt_icon":0},{"id":"2504161743","title":"天境生物上涨2.73%，报1.13美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2504161743","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2504161743?lang=zh_cn&edition=full","pubTime":"2025-01-17 22:34","pubTimestamp":1737124486,"startTime":"0","endTime":"0","summary":"1月17日，天境生物(IMAB)开盘上涨2.73%，截至22:34，报1.13美元/股，成交11.37万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/17223447576876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4526","BK4505","IMAB","BK4139","BK4535"],"gpt_icon":0},{"id":"2503674733","title":"天境生物上涨5.77%，报1.1美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2503674733","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503674733?lang=zh_cn&edition=full","pubTime":"2025-01-16 04:29","pubTimestamp":1736972986,"startTime":"0","endTime":"0","summary":"1月16日，天境生物(IMAB)盘中上涨5.77%，截至04:29，报1.1美元/股，成交13.78万美元。财务数据显示，截至2023年12月31日，天境生物收入总额2764.4万人民币，同比增长112.48%；归母净利润-14.66亿人民币，同比增长41.54%。大事提醒：8月28日，天境生物(美东)盘前披露2024财年中报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/01/16042947498587.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK4505","BK4535","BK4526","BK4139","IMAB"],"gpt_icon":0},{"id":"2503742676","title":"天境生物盘中异动 下午盘大幅拉升5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503742676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503742676?lang=zh_cn&edition=full","pubTime":"2025-01-16 04:29","pubTimestamp":1736972964,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日04时29分，天境生物股票出现异动，股价大幅拉升5.77%。截至发稿，该股报1.10美元/股，成交量12.7436万股，换手率0.16%，振幅6.73%。机构评级方面，在所有3家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。天境生物股票所在的生物技术行业中，整体涨幅为1.53%。该公司及其子公司主要在中华人民共和国及其他国家和地区从事免疫肿瘤学和免疫炎症疾病领域的转化性生物制剂的发现和开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116042924abac4077&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116042924abac4077&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4535","BK4139","BK4526","BK4505","IMAB"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.i-mabbiopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0894},{"period":"1year","weight":3.9208},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0066},{"period":"1month","weight":-0.0027},{"period":"3month","weight":0.0113},{"period":"6month","weight":0.0592},{"period":"1year","weight":0.1509},{"period":"ytd","weight":0.008}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"天境生物科技有限公司于2016年6月30日在开曼群岛注册成立，是一家处于临床阶段的创新生物药公司。公司聚焦肿瘤免疫和自身免疫疾病领域创新生物药的早期发现，药物开发和商业化，以填补尚未满足的重大医疗需求。公司的使命愿景是“持续开发创新生物药，真正改变患者生活”。为抓住机遇，履行使命，天境生物在“快速产品上市”和“快速概念验证”的双轮策略驱动下，通过自主研发和全球合作等多元化模式，聚焦于开发肿瘤免疫和自身免疫性疾病两大治疗领域临床前和临床阶段的创新生物药。通过自主研发，全球项目引进，迅速建立起拥有十多个具有全球竞争力的创新药管线，其中三个自主研发项目已在美国及中国进入临床一期试验，四个项目在中国分别处于临床二期和三期试验。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.051627},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.050827},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.121318},{"month":4,"riseRate":0.5,"avgChangeRate":0.06671},{"month":5,"riseRate":0.666667,"avgChangeRate":0.123895},{"month":6,"riseRate":0.833333,"avgChangeRate":0.225468},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.074812},{"month":8,"riseRate":0.333333,"avgChangeRate":0.044996},{"month":9,"riseRate":0.5,"avgChangeRate":-0.071754},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.02932},{"month":11,"riseRate":0.166667,"avgChangeRate":-0.018567},{"month":12,"riseRate":0.6,"avgChangeRate":0.049595}],"exchange":"NASDAQ","name":"I-MAB","nameEN":"I-MAB"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"I-MAB(IMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供I-MAB(IMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"I-MAB,IMAB,I-MAB股票,I-MAB股票老虎,I-MAB股票老虎国际,I-MAB行情,I-MAB股票行情,I-MAB股价,I-MAB股市,I-MAB股票价格,I-MAB股票交易,I-MAB股票购买,I-MAB股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"I-MAB(IMAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供I-MAB(IMAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}